MADISON – The Bill and Melinda Gates Foundation is best known for its work around global health and development, education and energy, but it’s also home to the equivalent of a venture capital fund that invests in emerging biotechnology and health companies.
Erik Iverson, who will become managing director of the Wisconsin Alumni Research Foundation this summer, helped get that fund off the ground during his seven-year stint at the foundation. Launched with about $400 million, the fund is now in the billion-dollar stratosphere and reaping returns on its early investments.
